ROCHESTER, New York, February 12 /PRNewswire/ --

Lucid, Inc. (www.lucid-tech.com) today announced the launch of its secure VivaNet(R) telemedicine server and network. The network is designed to transfer and manage clinical data between dermatology practitioners using Lucid's non-invasive VivaScope(R) Confocal Imagers with pathologists or other medical specialists.

Lucid's VivaScope(R) confocal imager microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need to excise tissue.

LEEDS, England, February 12 /PRNewswire/ --

- Teva UK Limited has Launched a New Website.

The new website, which is at http://www.tevauk.com, has been fully updated with a fresh new approach and contemporary design. Teva believes the new site will provide comprehensive information about the company to its customers, partners and employees alike.

BRUSSELS, Belgium, February 12 /PRNewswire/ --

The European Commission's new "Green Package" of legislation on climate change and renewable energy represents a significant potential opportunity for European utilities, according to a report released by The Brattle Group and Trilemma UK.

The Green Package sets targets that represent a step change in the energy market: save 20% of energy, increase the share of renewable energy to 20%, and cut greenhouse gas emissions by at least 20%, all by 2020. The joint report highlights the huge uncertainties in these targets, which make investment decisions difficult and risky, particularly regarding new power stations.

WALTHAM, Massachusetts, February 12 /PRNewswire/ --

- Institutional Investor News Features David Fiske of Lewtan's European Office in Inaugural Publication Honoring the "10 Rising Stars of Securitization"

Lewtan Technologies, Inc., provider of asset-backed securities surveillance data, analytics, software, and content for the global securitization industry, today announced that product marketing manager David Fiske has been named by Institutional Investor News as one of its 10 Rising Stars of Securitization.

AMSTERDAM, February 12 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial results for the full year 2007 on Wednesday, February 20, 2008 at 7:30 am Central European Time (CET). To discuss these results, the Company will conduct a conference call at 10 am CET. Netherlands Dial In: 0800-949-4517 (toll free); US Dial In: +1-866-291-4166 (toll free); UK Dial In: +44-207-107-0611. To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbiopharma.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.

LONDON, February 12 /PRNewswire/ -- Ideaworks3D, a leading developer of native mobile technology and applications, today announced that its Airplay native execution environment has been certified as a conformant implementation of the OpenKODE(TM) 1.0 API standard from the Khronos(TM) Group.

OpenKODE is a royalty-free, open standard that combines a set of native APIs to increase source portability for rich media and graphics applications. OpenKODE reduces mobile platform fragmentation by providing the OpenKODE Core cross-platform API for accessing operating system resources, and a media architecture for portable access to advanced mixed graphics acceleration.